Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucosal and epithelial surface proteins represent a broad and heterogeneous category of molecules rather than a single, specific therapeutic target. This group encompasses a wide variety of protein classes, including mucins (e.g., MUC1, MUC2), cell adhesion molecules (e.g., cadherins, claudins), and various apical receptors or transporters found on the surface of epithelial tissues lining the respiratory, gastrointestinal, and urogenital tracts. These proteins are essential for maintaining the physical and chemical barrier between the internal environment and external pathogens, as well as facilitating selective transport and cell-to-cell communication. While individual members of this group—such as MUC1 in oncology or specific integrins in inflammatory bowel disease—are well-validated drug targets, the collective term is too broad for precise pharmacological intervention. Consequently, this entry is classified as incorrect for the purposes of specific target annotation, as it lacks the molecular specificity required for drug development and clinical application.
Not applicable as this is a broad category of proteins rather than a single therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucosal and epithelial surface proteins.